Non-adherence to cytoreductive and/or antithrombotic drugs is frequent and associated with increased risk of complications in patients with polycythaemia vera or essential thrombocythaemia (OUEST Study)

0 avis

Non-adherence to cytoreductive and/or antithrombotic drugs is frequent and associated with increased risk of complications in patients with polycythaemia vera or essential thrombocythaemia (OUEST Study)

Archive ouverte

Edité par CCSD ; Ferrata Storti Foundation -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Archive ouverte | Le Calloch, Ronan | CCSD

International audience

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Archive ouverte | Le Calloch, Ronan | CCSD

International audience

Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?. Aspergillose cérébrale : une infection opportuniste émergente chez les patients traités par ibrutinib pour leucémie lymphoïde chronique ?

Archive ouverte | Gaye, E | CCSD

International audience. Ibrutinib is a novel oral covalent inhibitor of Bruton's tyrosine kinase (BTK). It has been approved for the treatment of relapsing chronic lymphocytic leukemia (CLL), or CLL with high-risk c...

Chargement des enrichissements...